J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Promacta

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

54 API Suppliers, 21 USDMF, 3 JDMF, 5 EU WC, 4 KDMF, 15 NDC API, 33 Listed Suppliers, $ API Reference Price

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

87 FDF Dossiers, 29 FDA Orange Book, 10 Europe, 4 Canada, 16 Australia, 2 South Africa, 26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 12.5MG ACID, TABLET;ORAL - EQ 25MG ACID, TABLET;ORAL - EQ 50MG ACID, TABLET;ORAL - EQ 75MG ACID

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 14 SPI Pharma, 7 DKSH, 2 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 12 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 10 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 19 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 14 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Coating Systems & Additives, 47 Fillers, Diluents & Binders, 26 Controlled & Modified Release, 22 Direct Compression, 20 Thickeners and Stabilizers, 20 Disintegrants & Superdisintegrants, 18 Solubilizers, 16 Co-Processed Excipients, 16 Granulation, 15 Taste Masking, 13 Chewable & Orodispersible Aids, 13 Parenteral, 12 Lubricants & Glidants, 10 Film Formers & Plasticizers, 8 Topical, 8 Rheology Modifiers, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 27 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Regulatory FDF Prices, 15 Annual Reports

MARKET PLACE

13 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

101 US Patents, 13 US Exclusivities, 9 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP

2 USP

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/06/2025	Aurobindo Pharma Limited	India	Aging Life Science Co., Ltd.	20250623-211-J-1926	Eltrombopagolamine	2025-06-23	Apitoria Pharma Private Limited Unit-I	India	Unit-I, Sy.No. 379, 385, 386, 388 - 396, Borpatla Village, Hatnoora Mandal, Sangareddy District, Telangana, 502 296 INDIA
28/06/2025	Hetero Drugs	India	Lee Sung International Co., Ltd.	20250213-211-J-1763	Eltrombopagolamine	2025-02-13	Hetero Drugs Limited (Unit-I)	India	Survey No. 213, 214 and 255, Bonthapally Village, Gummadidala Mandal, Sangareddy District-502313, Telangana, India

Promacta

Promacta

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

54 API Suppliers

21 USDMF

3 JDMF

5 EU WC

4 KDMF

15 NDC API

33 Listed Suppliers

$ API Reference Price

INTERMEDIATES

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

87 FDF Dossiers

29 FDA Orange Book

10 Europe

4 Canada

16 Australia

2 South Africa

26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 12.5MG ACID

TABLET;ORAL - EQ 25MG ACID

TABLET;ORAL - EQ 50MG ACID

TABLET;ORAL - EQ 75MG ACID

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

14 SPI Pharma

7 DKSH

2 Pharm-RX Chemical

4 Faran Shimi Pharmaceutical

1 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

2 Actylis

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

12 BASF

1 Bioplus Life Sciences

1 Clariant

10 Corel Pharma Chem

3 DFE Pharma

10 Gangwal Chemicals

5 Ideal Cures

2 Ingredion Pharma Solutions

19 Kerry

3 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

3 Novo Excipients

3 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

14 Roquette

12 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Coating Systems & Additives

47 Fillers, Diluents & Binders

26 Controlled & Modified Release

22 Direct Compression

20 Thickeners and Stabilizers

TABLET;ORAL - EQ 100MG ACID Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons